-
Thai, Myanmar military chiefs meet as post-coup thaw progresses
-
Russian strikes kill 13 in Kyiv, surrounding region
-
Asian stocks rally as US Treasury steps in to ease bond fears
-
'Simply lovely': Verstappen signs new Red Bull contract until 2030
-
Verstappen signs new Red Bull contract until 2030: team
-
Australia coach Walters heading to St Helens after World Cup
-
What property giant Evergrande's sentence means for China's economy
-
China jails founder, fines disgraced property giant Evergrande
-
Australian prosecutors demand life in prison for mushroom killer
-
Russian strikes kill 12 in Kyiv, surrounding region
-
Fallout far-reaching for Australian Rules after latest scandal
-
US India ambassador's Kashmir remarks rile Pakistan; envoy summoned
-
Rafts on Rome's Tiber River cool down overheated tourists
-
In Senegal's Saint-Louis, traces of slave-trading past fade away
-
Top seeds Sabalenka, Zverev stunned in Cincinnati fourth round
-
Russian strikes kill 9 in Kyiv, surrounding region
-
Australia says relations with Israel 'difficult' after aid worker death
-
Messi scores first goal since father's death in Miami draw
-
PSG start Ligue 1 defence with eye on Champions League hat-trick
-
Mercedes and Max: What to watch as F1 returns for Dutch GP
-
Arsenal can become world's best club: Arteta
-
'People, not robots': Ukraine's soldiers justify human role amid drone revolution
-
Japan's King Kazu, 59, scores twice from spot to make cup history
-
North Sea drilling tests UK govt climate pledge
-
Kyiv's desperate vendors persevere outside obliterated flea market
-
'Ray of hope': Gaza seed bank rebuilds after wartime destruction
-
Australia races to shield little penguins from H5N1 bird flu
-
Mourinho begins second Real Madrid reign with Barca in his sights
-
Messi scores first goal since father's death
-
'More confrontational': Iran's new hardline security leadership
-
US national debt exceeds $40 trillion for first time
-
UK summons Israeli envoy over West Bank settlement project
-
Brazilian narco violence spills over into tranquil Bolivia
-
Trump vows 'tremendous' economic costs on Iran partners
-
Trump's devoted 'human printer' in media glare
-
Germany, France, UN condemn far-right Israeli minister's 'inhumane' Gaza remarks
-
Eagle Plains' Partner Xcite Uranium Inc. Commences Drill Program at the Don Lake Uranium Project, Saskatchewan
-
HM Exploration Announces DTC Eligibility of Its Common Shares in the United States
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 20
-
Great Western Mining Corporation plc Announces Holding(s) in Company
-
Top seed Zverev bundled out by Paul in rain-hit Cincinnati upset
-
Prince Harry and Meghan moving back to UK: British press
-
WADA pledges vigilance on Russian athletes ahead of 2028 Olympics
-
Lee, Baena guide Atletico to opening Liga win over Malaga
-
NASA satellite rescue mission fails
-
Ecuador intel chief, five Americans killed in Kenya helicopter crash
-
Cobolli halts Jodar to reach Cincinnati quarter-finals
-
Robinson and Tongue share match ball after dismissing Pakistan
-
As election looms, Netanyahu puts Turkey in Israel's crosshairs
-
Israel army admits firing on car in death of five-year-old Hind Rajab
AVTRMed Selected as Member of NVIDIA Inception Program, Advancing its Enterprise AI Platform for Healthcare Delivery
Selection validates AVTRMed's technical architecture and accelerates its go-to-market strategy for scaling its intelligent automation platform
DAKOTA DUNES, SOUTH DAKOTA / ACCESS Newswire / February 9, 2026 / AVTRMed, Inc., a healthcare AI company building autonomous clinical workflow solutions, today announced its acceptance into the NVIDIA Inception program, a global initiative supporting startups developing transformative technologies in artificial intelligence and accelerated computing.
The NVIDIA Inception program provides AVTRMed with access to NVIDIA's advanced AI frameworks, infrastructure, technical expertise and capabilities to scale its eye care platform and later expand to additional healthcare verticals. Selection into the program validates AVTRMed's technical architecture and solidifies its position in the rapidly growing AI-enabled healthcare sector.
"Joining NVIDIA Inception is a strategic milestone that validates our mission and strengthens our foundation for sustained growth," says Dr. Steven Ferguson, CEO of AVTRMed. "This collaboration empowers AVTRMed to deliver high-impact clinical and operational AI solutions at scale, alongside leading innovators in healthcare AI."
AVTRMed is developing a next-generation platform designed to address structural inefficiencies in healthcare delivery through intelligent, autonomous digital workflows. The company's AI Clinic Assistant is currently deployed in live clinical eye care environments, demonstrating meaningful reductions in administrative workload and improvements in patient appointment adherence. As healthcare organizations increasingly seek AI solutions that deliver immediate ROI and integrate seamlessly with existing infrastructure, AVTRMed's focus on performance and enterprise deployment positions the company to capture value in a market undergoing fundamental transformation.
NVIDIA Inception fuels AVTRMed's ability to scale and future-proof its platform without compromising the rigorous security and compliance that healthcare demands.
For more information about AVTRMed and its AI platform, visit AVTRMed.com or connect with the company on LinkedIn.
About AVTRMed, Inc.
AVTRMed is a healthcare AI company building scalable platforms that augment clinical and operational workflows through advanced artificial intelligence. The company's mission is to enable more efficient, accessible and human-centered healthcare delivery. AVTRMed's AI Clinic Assistant platform serves eye care practices with autonomous solutions for patient engagement and administrative automation. Learn more at www.avtrmed.com.
About NVIDIA Inception
NVIDIA Inception is designed to nurture startups revolutionizing industries with technological advancements. The program provides critical go-to-market support, expertise, and technology to members across the globe, spanning diverse industries from healthcare and finance to automotive and manufacturing. For more information, visit nvidia.com/en-us/startups.
END
Media Contact:
Brian Regan, COO
Phone: (919) 229-9594
Email: [email protected]
SOURCE: AVTRMed
View the original press release on ACCESS Newswire
A.Clark--AT